A story of pa/bsa and biomarkers to diagnose pulmonary hypertension in patients with severe aortic valve stenosis—the rise of igf-bp2 and gdf-15

HIGHLIGHTS

• who: Joseph Kletzer and colleagues from the Department of Internal Medicine II, Division of Cardiology, Paracelsus Medical University of Salzburg, Salzburg, Austria have published the Article: A Story of PA/BSA and Biomarkers to Diagnose Pulmonary Hypertension in Patients with Severe Aortic Valve Stenosisu2014The Rise of IGF-BP2 and GDF-15, in the Journal: (JOURNAL)
• what: This study compared established and novel biomarkers with the PA/BSA value to detect PH in patients with severe AS. Compared to the work , this study evaluated the two-year mortality as opposed to the one-year mortality, with . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.